Ambrx Biopharma Inc.

NYSE: AMAM · Real-Time Price · USD
28.00
0.02 (0.07%)
At close: Mar 06, 2024, 9:00 PM

Ambrx Biopharma Statistics

Share Statistics

Ambrx Biopharma has 63.29M shares outstanding. The number of shares has increased by 0% in one year.

63.29M
0%
0%
n/a
n/a
848
0.04%

Short Selling Information

n/a
n/a
n/a
n/a

Valuation Ratios

The PE ratio is -1.12 and the forward PE ratio is null. Ambrx Biopharma's PEG ratio is 0.03.

-1.12
n/a
11.84
n/a
0.74
-1.26
0.03
Financial Ratio History

Enterprise Valuation

Ambrx Biopharma has an Enterprise Value (EV) of 44M.

5.94
-0.79
-0.64
-0.63

Financial Position

The company has a current ratio of 5.44, with a Debt / Equity ratio of 0.1.

5.44
5.21
0.1
-0.21
-0.17
-58.97

Financial Efficiency

Return on Equity is -66.18% and Return on Invested Capital is -45.09%.

-66.18%
-53.07%
-45.09%
$85,080.46
$-896,505.75
87
0.05
n/a

Taxes

1.94M
-2.55%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is -2.36, so Ambrx Biopharma's price volatility has been lower than the market average.

-2.36
n/a
25.33
15.99
82.2
1,943,941

Income Statement

In the last 12 months, Ambrx Biopharma had revenue of 7.4M and earned -78M in profits. Earnings per share was -2.02.

7.4M
7.4M
-57.08M
-78M
-55.79M
-64.46M
-2.02
Full Income Statement

Balance Sheet

The company has 55.61M in cash and 11.98M in debt, giving a net cash position of 43.63M.

55.61M
11.98M
43.63M
-291.63M
271.5M
215.55M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -68.67M and capital expenditures -1.05M, giving a free cash flow of -69.73M.

-68.67M
-1.05M
-69.73M
-1.81
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -771.16% and -1053.72%.

100%
-771.16%
-1027.55%
-1053.72%
-753.69%
-771.16%
-942.03%

Dividends & Yields

AMAM does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
-89%
-79.57%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for AMAM.

n/a
n/a
n/a
n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

34.85
2